Mayne Pharma Group Ltd

HG6

Company Profile

  • Business description

    Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women’s Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women’s Health segment distributes branded women’s health products in the U.S. International’s segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.

  • Contact

    1538 Main North Road
    Salisbury South
    SalisburySA5106
    AUS

    T: +61 882092666

    https://www.maynepharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Distribution

    Fiscal Year End

    30 June 2027

    Employees

    160

Stocks News & Analysis

stocks

ASX healthcare share remains undervalued ahead of earnings

Margin recovery remains the key driver for this ASX healthcare share.
stocks

Alphabet earnings: Strong AI monetization continues to spearhead results

We maintain our fair value estimate for wide-moat Alphabet.
stocks

AMD: We’re pleased with Anthropic Partnership ahead of advancing AI event

We’re encouraged that AMD will count Anthropic as a third leading AI customer, in addition to OpenAI and Meta.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,941.5032.70-0.36%
CAC 408,372.280.000.00%
DAX 4025,099.00335.881.36%
Dow JONES (US)51,947.25235.600.46%
FTSE 10010,736.2397.060.91%
HKSE24,963.23247.58-0.98%
NASDAQ24,975.82161.87-0.64%
Nikkei 22564,611.151,811.45-2.73%
NZX 50 Index13,772.2923.02-0.17%
S&P 5007,411.983.680.05%
S&P/ASX 2008,772.3023.40-0.27%
SSE Composite Index3,814.2062.58-1.61%

Market Movers